Effect of enzyme inhibitors and influence of ionic strength during the interaction of EAC1-3 and C5.
D000818:Animals; D000906:Antibodies; D007611:Aprotinin / Q000494:pharmacology*; D001666:Binding Sites, Antibody; D003172:Complement C1; D003176:Complement C3; D003182:Complement C5; D003165:Complement System Proteins; D004912:Erythrocytes / Q000276:immunology*; D006168:Guinea Pigs; D006461:Hemolysis / Q000187:drug effects; D009994:Osmolar Concentration; D014148:Tranexamic Acid / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000906:Antibodies; D003172:Complement C1; D003176:Complement C3; D003182:Complement C5; D014361:Trypsin Inhibitors; D014148:Tranexamic Acid; D003165:Complement System Proteins; D007611:Aprotinin